Mechanisms of intracellular killing of Toxoplasma gondiiREMINGTON, J. S.Médecine et maladies infectieuses. 1985, Vol 15, Num 11, pp 681-682, issn 0399-077XArticle

Toxoplasmose au cours du SIDA = Toxoplasmosis in AIDSLEPORT, C; REMINGTON, J. S.La Presse médicale (1983). 1992, Vol 21, Num 25, pp 1165-1171, issn 0755-4982Article

Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2⁺ and Lyt-1⁺, L3T4⁺ T cells in miceSUZUKI, Y; REMINGTON, J. S.The Journal of immunology (1950). 1988, Vol 140, Num 11, pp 3943-3946, issn 0022-1767Article

Importance of membrane-bound antigens of Toxoplasma gondii and their fixation for serodiagnosis of toxoplasmic encephalitis in patients with acquired immunodeficiency syndromeSUZUKI, Y; REMINGTON, J. S.Journal of clinical microbiology (Print). 1990, Vol 28, Num 10, pp 2354-2356, issn 0095-1137, 3 p.Article

Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondiiSUZUKI, Y; QING YANG; REMINGTON, J. S et al.The Journal of parasitology. 1995, Vol 81, Num 6, pp 1032-1034, issn 0022-3395Article

Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediatesCANDOLFI, E; HUNTER, C. A; REMINGTON, J. S et al.Infection and immunity. 1994, Vol 62, Num 5, pp 1995-2001, issn 0019-9567Article

Detection of antigens in urine during acute toxoplasmosisHUSKINSON, J; STEPICK-BIEK, P; REMINGTON, J. S et al.Journal of clinical microbiology (Print). 1989, Vol 27, Num 5, pp 1099-1101, issn 0095-1137Article

Zidovudine antagonizes the action of pyrimethamine in experimental infection with Toxoplasma gondiiISRAELSKI, D. M; TOM, C; REMINGTON, J. S et al.Antimicrobial agents and chemotherapy. 1989, Vol 33, Num 1, pp 30-34, issn 0066-4804Article

Comparison of methods for quantitating antigen-specific immunoglobulin M antibody with a reverse enzyme-linked immunosorbent assaySIEGEL, J. P; REMINGTON, J. S.Journal of clinical microbiology (Print). 1983, Vol 18, Num 1, pp 63-70, issn 0095-1137Article

Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in miceARAUJO, F. G; SUZUKI, Y; REMINGTON, J. S et al.European journal of clinical microbiology & infectious diseases (Print). 1996, Vol 15, Num 5, pp 394-397, issn 0934-9723Article

Vaccination of mice with the protective F3G3 antigen of Toxoplasma gondii activates CD4⁺ but not CD8⁺ T cells and induces toxoplasma specific IgG antibodyBRINKMANN, V; REMINGTON, J. S; SHARMA, S. D et al.Molecular immunology. 1993, Vol 30, Num 4, pp 353-358, issn 0161-5890Article

Synergistic combination of Azithromycin and sulfadiazine for treatment of toxoplasmosis in miceARAUJO, F. G; LIN, T; REMINGTON, J. S et al.European journal of clinical microbiology & infectious diseases (Print). 1992, Vol 11, Num 1, pp 71-73, issn 0934-9723Article

Tissue culture isolation of Toxoplasma from blood of a patient with AIDSHOFFLIN, J. M; REMINGTON, J. S.Archives of internal medicine (1960). 1985, Vol 145, Num 5, pp 925-926, issn 0003-9926Article

Effect of pregnancy on augmentation of natural killer cell activity by corynebacterium parvum and toxoplasma gondiiLUFT, B. J; REMINGTON, J. S.The Journal of immunology (1950). 1984, Vol 132, Num 5, pp 2375-2380, issn 0022-1767Article

Partially purified antigen preparations of Toxoplasma gondii protect against lethal infection in miceARAUJO, F. G; REMINGTON, J. S.Infection and immunity. 1984, Vol 45, Num 1, pp 122-126, issn 0019-9567Article

Rifabutin is active in murine models of toxoplasmosisARAUJO, F. G; SLIFER, T; REMINGTON, J. S et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 3, pp 570-575, issn 0066-4804Article

Biology of Toxoplasma gondiiSIN-YEW WONG; REMINGTON, J. S.AIDS (London). 1993, Vol 7, Num 3, pp 299-316, issn 0269-9370Article

The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazineARAUJO, F. G; LIN, T; REMINGTON, J. S et al.The Journal of infectious diseases. 1993, Vol 167, Num 2, pp 494-497, issn 0022-1899Article

Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondiiARAUJO, F. G; HUSKINSON, J; REMINGTON, J. S et al.Antimicrobial agents and chemotherapy. 1991, Vol 35, Num 2, pp 293-299, issn 0066-4804, 7 p.Article

Role of gamma interferon in Toxoplasma gondii infectionSUBAUSTE, C. S; REMINGTON, J. S.European journal of clinical microbiology & infectious diseases (Print). 1991, Vol 10, Num 2, pp 58-67, issn 0934-9723Article

Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferonSUZUKI, Y; CONLEY, F. K; REMINGTON, J. S et al.Infection and immunity. 1990, Vol 58, Num 9, pp 3050-3055, issn 0019-9567Article

Proceedings/Update and advances in intravenous therapy with trimethoprim-sulfamethoxazole, symposium, San Francisco, CA, July 15, 1985REMINGTON, J. S.Reviews of infectious diseases. 1987, Vol 9, pp S153-S229, issn 0162-0886, suppl. 2Conference Proceedings

Acute Toxoplasma infection among family members of patients with acute lymphadenopathic toxoplasmosisLUFT, B. J; REMINGTON, J. S.Archives of internal medicine (1960). 1984, Vol 144, Num 1, pp 53-56, issn 0003-9926Article

Tularemia presenting as community-acquired pneumonia : Implications in the era of managed careFREDRICKS, D. N; REMINGTON, J. S.Archives of internal medicine (1960). 1996, Vol 156, Num 18, pp 2137-2140, issn 0003-9926Article

Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosisCANDOLFI, E; HUNTER, C. A; REMINGTON, J. S et al.Infection and immunity. 1995, Vol 63, Num 3, pp 751-756, issn 0019-9567Article